Insulin Degludec Titration Using Mobile Insulin Dosing System

NACompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

August 8, 2019

Study Completion Date

September 15, 2019

Conditions

Type 2 Diabetes Mellitus

Interventions

DEVICE

Glooko Mobile Insulin Dosing System(MIDS)

Mobile Insulin Dosing System (MIDS) for all long acting insulin degludec titration management

Trial Locations (1)

Scripps Whittier Diabetes Institute, San Diego